88 related articles for article (PubMed ID: 25445049)
1. Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies.
Hao HZ; He AD; Wang DC; Yin Z; Zhou YJ; Liu G; Liang ML; Da XW; Yao GQ; Xie W; Xiang JZ; Ming ZY
Eur J Pharmacol; 2015 Jan; 746():63-9. PubMed ID: 25445049
[TBL] [Abstract][Full Text] [Related]
2. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.
Xiang K; Liu G; Zhou YJ; Hao HZ; Yin Z; He AD; Da XW; Xiang JZ; Wang JL; Ming ZY
Thromb Res; 2014 Feb; 133(2):211-7. PubMed ID: 24332167
[TBL] [Abstract][Full Text] [Related]
3. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
[TBL] [Abstract][Full Text] [Related]
4. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice.
Chen J; De S; Damron DS; Chen WS; Hay N; Byzova TV
Blood; 2004 Sep; 104(6):1703-10. PubMed ID: 15105289
[TBL] [Abstract][Full Text] [Related]
5. Atractylodes lactone compounds inhibit platelet activation.
Chen Y; Yang W; Guo L; Wu X; Zhang T; Liu J; Zhang J
Platelets; 2017 Mar; 28(2):194-202. PubMed ID: 27560602
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of neferine in the modulation of human platelet function.
Yang RP; Zhou YJ; Song W; Yin Z; He AD; Ming ZY
Eur J Pharmacol; 2019 Nov; 862():172626. PubMed ID: 31445013
[TBL] [Abstract][Full Text] [Related]
8. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
9. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
10. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
[TBL] [Abstract][Full Text] [Related]
11. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
12. Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.
Su W; Chen Y; Wang C; Ding X; Rwibasira G; Kong Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):283-289. PubMed ID: 27012197
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
14. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
[TBL] [Abstract][Full Text] [Related]
15. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hypoxia-Inducible Factor Prolyl-Hydroxylase Modulates Platelet Function.
Gu W; Qi J; Zhang S; Ding Y; Qiao J; Han Y
Thromb Haemost; 2022 Oct; 122(10):1693-1705. PubMed ID: 35477177
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation.
Bertoni A; Rastoldo A; Sarasso C; Di Vito C; Sampietro S; Nalin M; Bagarotti A; Sinigaglia F
Steroids; 2012 Feb; 77(3):260-8. PubMed ID: 22182832
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway.
Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N
J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434
[TBL] [Abstract][Full Text] [Related]
20. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
